Brisbane, Ca., USA - December 17, 2010, Brisbane, Ca., USA - InterMune, a pharmaceutical company, announced the creation of its top management team in charge for Europe.
Article continues below
Senior Vice President and Managing Director, Europe is Giacomo Di Nepi. Mr. Di Nepi joined InterMune in this role in November of 2009. Before Joining InterMune he was Chief Executive Officer of Takeda Pharmaceuticals Europe, where he drove the EU operations and geographic expansion.
Prior to that, Mr. Di Nepi was a member of the Executive Committee of Novartis Pharma AG as Global Head for the Transplantation and Infectious Disease business unit. He previously served as Chief Executive Officer of Novartis Italy. Before entering the pharmaceutical industry, he was a partner in the healthcare practice of McKinsey & Co.
Mr. Di Nepi will be based in the European headquarters in Basel, Switzerland and has worked in Switzerland, the UK, the US and Italy.
Senior Vice President, EU Medical and Global Medical Advisor is Frank T. Weber, M.D. Dr. Weber has 20 years of industry experience, having served most recently as Chief Medical Officer at Merck Serono where he played a key role in the registration and reimbursement processes in Europe for Erbitux® (cetuximab).
Dr. Weber previously served in various medical affairs positions at American Cyanamid/Lederle, Sythelabo and Merck KGaA. He also worked on the national reimbursement side as Medical Director with MedNet, a Munich Re/United Health Care joint venture.
Dr. Weber began his career in healthcare as a surgeon and immunologist. Dr. Weber has worked in Germany, Switzerland, France, the UK and the United States. He will be based in the European headquarters in Basel, Switzerland.
Senior Vice President and General Manager, Germany if Markus Leyck Dieken, M.D. Dr. Dieken joins InterMune from Novartis, where he was Head of the European Region for the vaccines business and Managing Director of Novartis-Behring's German operations.
Prior to Novartis, Dr. Dieken served for 10 years with Novo Nordisk Germany in various roles in Medical Affairs, Marketing and Sales, and then as General Manager of the German subsidiary and Vice President, Central Europe. He has worked in Germany and Switzerland. Dr. Leyck Dieken will be based in Berlin, Germany.
Vice President, Sales and Marketing, Europe is Manuela Maronati. Ms. Maronati brings 15 years of sales and marketing experience, including the past seven years with Amgen where she served as an International Senior Marketing Manager on the Neupogen (filgrastim) franchise, and where she previously launched a new medical device for use across several Amgen products. ■